Identification of different forms of human C4b-binding proteinlacking β-chain and protein S binding abilityHESSING, M; KANTERS, D; HACKENG, T. M et al.Thrombosis and haemostasis. 1990, Vol 64, Num 2, pp 245-250, issn 0340-6245, 6 p.Article

The binding of high molecular weight kininogen to cultured human endothelial cellsVAN IWAARDEN, F; DE GROOT, P. G; BOUMA, B. N et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 10, pp 4698-4703, issn 0021-9258Article

Activation of factor B of the complement system by kallikrein and its light chainHIEMSTRA, P. S; DAHA, M. R; BOUMA, B. N et al.Thrombosis research. 1985, Vol 38, Num 5, pp 491-503, issn 0049-3848Article

The association between the lupus anticoagulant and cerebral infarction in systemic lupus erythematosusDERKSEN, R. H. W. M; BOUMA, B. N; KATER, L et al.Scandinavian journal of rheumatology. 1986, Vol 15, Num 2, pp 179-184, issn 0300-9742Article

The binding site of human C4b-binding protein on complement C4 is localized in the α'-chainHESSING, M; VAN 'T VEER, C; BOUMA, B. N et al.The Journal of immunology (1950). 1990, Vol 144, Num 7, pp 2632-2636, issn 0022-1767Article

Fibrinolysis and the contact system : A role for factor XI in the down-regulation of fibrinolysisBOUMA, B. N; MEIJERS, J. C. M.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 243-250, issn 0340-6245Article

Purified human plasma kallikrein does not stimulate but primes neutrophils for superoxide productionZIMMERLI, W; HUBER, I; BOUMA, B. N et al.Thrombosis and haemostasis. 1989, Vol 62, Num 4, pp 1121-1125, issn 0340-6245Article

The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosusDERKSEN, R. H. W. M; BOUMA, B. N; KATER, L et al.Scandinavian journal of rheumatology. 1987, Vol 16, Num 3, pp 185-192, issn 0300-9742Article

Failure to detect variant (CRM⁺) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgroundsSAITO, H; RATNOFF, O. D; BOUMA, B. N et al.The Journal of laboratory and clinical medicine. 1985, Vol 106, Num 6, pp 718-722, issn 0022-2143Article

Acute inhibitory effect of alcohol on fibrinolysisVAN DE WIEL, A; VAN GOLDE, P. M; KRAAIJENHAGEN, R. J et al.European journal of clinical investigation. 2001, Vol 31, Num 2, pp 164-170, issn 0014-2972Article

Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemiaMEIJERS, J. C. M; OUDIJK, E.-J. D; MOSNIER, L. O et al.British journal of haematology. 2000, Vol 108, Num 3, pp 518-523, issn 0007-1048Article

The identification and significance of a Thr→Pro polymorphism in kringle IV type 8 of apolipoprotein(a)PRINS, J; LEUS, F. R; VAN DER HOEK, Y. Y et al.Thrombosis and haemostasis. 1997, Vol 77, Num 5, pp 949-954, issn 0340-6245Article

Structural and functional aspects of the carbohydrate moieties of apolipoprotein B-100 and plasminogenPEKELHARING, H. L. M; KLEINVELD, H. A; BOUMA, B. N et al.Clinical chemistry and enzymology communications (Print). 1995, Vol 6, Num 5, pp 329-343, issn 0892-2187Article

Changes in haemostatic factors and activation products after exercise in healthy subjects with different agesVAN DEN BURG, P. J. M; HOSPERS, J. E. H; VAN VLIET, M et al.Thrombosis and haemostasis. 1995, Vol 74, Num 6, pp 1457-1464, issn 0340-6245Article

Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectinDE BOER, H. C; PREISSNER, K. T; BOUMA, B. N et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 4, pp 2264-2268, issn 0021-9258Article

Structure-function studies on human C4b-binding protein using monoclonal antibodiesHESSING, M; KANTERS, D; HEIJNEN, H. F. G et al.European journal of immunology. 1991, Vol 21, Num 9, pp 2077-2085, issn 0014-2980Article

Methylprednisolone induces activation of the contact system in a dose-dependent manner. An In vitro studyROEISE, O; NUIJENS, J. H; HACK, C. E et al.Thrombosis research. 1990, Vol 57, Num 6, pp 877-888, issn 0049-3848, 12 p.Article

Chorea in systemic Lupus erythematosus and «Lupus-like» disease: association with antiphospholipid antibodiesASHERSON, R. A; DERKSEN, R. H. W. M; HARRIS, E. N et al.Seminars in arthritis and rheumatism. 1987, Vol 16, Num 4, pp 253-259, issn 0049-0172Article

Oral contraceptives reduce total protein S, but not free protein 5HUISVELD, I. A; HOSPERS, J. E. H; MEIJERS, J. C. M et al.Thrombosis research. 1987, Vol 45, Num 1, pp 109-114, issn 0049-3848Article

Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutationKEMMEREN, J. M; ALGRA, A; MEIJERS, J. C. M et al.Thrombosis and haemostasis. 2002, Vol 87, Num 2, pp 199-205, issn 0340-6245, 7 p.Article

Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction productsVAN DEN BURG, P. J. M; HOSPERS, J. E. H; MOSTERD, W. L et al.Journal of applied physiology (1985). 2000, Vol 88, Num 5, pp 1558-1564, issn 8750-7587Article

The role of alcohol in the anti low density lipoprotein oxidation activity of red wineVAN GOLDE, P. H. M; SLOOTS, L. M; VERMEULEN, W. P et al.Atherosclerosis. 1999, Vol 147, Num 2, pp 365-370, issn 0021-9150Article

Factor XI dependent and independent activation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in plasma associated with clot formationBOUMA, B. N; MOSNIER, L. O; MEIJERS, J. C. M et al.Thrombosis and haemostasis. 1999, Vol 82, Num 6, pp 1703-1708, issn 0340-6245Article

Factor XI activation by meizothrombin : Stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamineVON DEM BORNE, P. A. K; MOSNIER, L. O; TANS, G et al.Thrombosis and haemostasis. 1997, Vol 78, Num 2, pp 834-839, issn 0340-6245Article

Kinetics of factor VIII-von Willebrand factor associationVLOT, A. J; KOPPELMAN, S. J; MEIJERS, J. C. M et al.Blood. 1996, Vol 87, Num 5, pp 1809-1816, issn 0006-4971Article